Cindy Cohen, MBA
About Cindy Cohen, MBA
Cindy Cohen, MBA, is a Senior Director of Program Management with over 20 years of experience in the biopharmaceutical industry, specializing in clinical drug development and post-launch evidence generation. She currently works at Day One Biopharmaceuticals and has held various leadership roles at notable companies such as Myovant Sciences, Aimmune Therapeutics, and Genentech.
Current Role at Day One Biopharmaceuticals
Cindy Cohen serves as the Senior Director of Program Management at Day One Biopharmaceuticals. She has held this position since 2020, contributing her extensive experience in the biopharmaceutical industry. In this role, she focuses on overseeing clinical drug development processes and managing teams to ensure effective execution of projects. Her strategic approach enables her to address complex organizational challenges within the company.
Previous Experience in Biopharmaceuticals
Before joining Day One Biopharmaceuticals, Cindy Cohen worked at Myovant Sciences as the Senior Director of Program and Alliance Management from 2018 to 2020. Prior to that, she held the position of Associate Director of Project Management at Aimmune Therapeutics for nearly a year in 2017. Her career also includes a significant tenure at Genentech, where she worked for 14 years in Project/Portfolio Management across various departments, including IT, Product Development, and US Medical Affairs.
Education and Expertise
Cindy Cohen earned her Master of Business Administration (M.B.A.) from the University of California, Berkeley, Haas School of Business, completing her studies from 2015 to 2016. She also holds a Bachelor of Science (B.S.) degree in Biochemistry and Cell Biology from UC San Diego. Her educational background, combined with over 20 years of experience in clinical drug development and post-launch evidence generation, equips her with the expertise to manage complex projects effectively.
Professional Skills and Strengths
Cindy Cohen is recognized for her ability to act as a strategic thought partner within organizations. Her skills include navigating complex organizational challenges and managing teams that oversee clinical drug development processes. This combination of strategic insight and operational expertise positions her as a valuable asset in the biopharmaceutical industry.